Clinical Trial Update: A Study to Evaluate Persistence of Immune Responses After Post-exposure Prophylaxis of Rabipur® (Purified Chicken-embryo Cell Rabies Vaccine) in Chinese Children [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating the durability of immune responses after post-exposure prophylaxis with Rabipur rabies vaccine in Chinese children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rabies

Drugs mentioned

• Rabipur (Purified Chick-embryo Cell Rabies Vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Virus Diseases | Phase 4 | Status: COMPLETED